alcoholic prolamine solution

a prolaminacid solution containing zein, diatrizoate sodium tetrahydrate, poppy-seed oil & propylene glycol; polymerizes in an aqueous medium in approx 15 min; used in abdominal surgery for occluding the pancreatic duct system

Also Known As:

Networked: 93 relevant articles (13 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Dubois, Josée: 2 articles (05/2006 - 06/2003)
2.	Batisse, F: 1 article (04/2016)
3.	Bonnard, C: 1 article (04/2016)
4.	Herbreteau, D: 1 article (04/2016)
5.	Schmitt, A: 1 article (04/2016)
6.	Vendeuvre, T: 1 article (04/2016)
7.	Bass, Alf: 1 article (11/2009)
8.	Bruce, Colin E: 1 article (11/2009)
9.	Garg, Neeraj K: 1 article (11/2009)
10.	George, Harvey L: 1 article (11/2009)

Related Diseases

1.	Lymphangioma (Cavernous Lymphangioma) 10/01/2000 - "In our experience, Ethibloc is particularly appropriate for the treatment of large lymphangiomas." 10/01/2000 - "It materialized as an Ethibloc exteriorization among 5 patients suffering from venous angiomas and 3 patients suffering from lymphangiomas and as an inflammatory lump for 2 venous angiomas carriers and for 4 lymphangiomas carriers. " 09/01/1997 - "The most frequent complication was leakage of Ethibloc without important sequelae in 10 of the 14 lymphangiomas. " 01/01/1997 - "Between 1987 and 1993, 20 patients with a superficial macrocystic lymphangioma were treated by percutaneous injection of Ethibloc in order to reduce the volume of the CL, with a minimum follow-up of 1 year. " 10/01/1996 - "[Treatment with Ethibloc of lymphangiomas and venous angiomas]."
2.	Chronic Pancreatitis 01/01/1998 - "To achieve the burned out state of chronic pancreatitis, occlusion of the pancreatic duct was first attempted by our team with Ethibloc at ERCP. " 01/01/1989 - "Alcohol-induced chronic pancreatitis in rats after temporary occlusion of biliopancreatic ducts with Ethibloc." 01/01/1987 - "Altogether, Whipple's procedure plus intraoperative Ethibloc occlusion of the residual pancreatic duct system seems suitable for termination of the inflammatory process and thus preservation of residual endocrine pancreatic function in chronic pancreatitis." 12/17/1981 - "On the basis of a standardized, improved surgical technique, and the introduction of pancreatic ductal occlusion with Ethibloc to prevent recurrence, we have succeeded in achieving a considerable improvement in the early and late results of partial duodenopancreatectomy in the treatment of chronic pancreatitis; this improvement is reflected in a marked reduction in the surgical mortality rate from, formerly, 8.2 in 49 to 0.86% in 116 operations, together with, to date, very good late results, with freedom from symptoms in 90.2%, a recurrence rate of 1.1%, and a postoperative increase in weight of, on average, 7.8 kg in 85% of the cases so treated." 04/01/1990 - "We conclude that partial pancreaticoduodenectomy with occlusion of the pancreatic duct with Ethibloc is the procedure of choice in severe chronic pancreatitis mainly affecting the head of the gland."
3.	Atrophy 06/01/1990 - "In a prospective follow-up study of 23 patients, Ethibloc duct occlusion was shown to be highly effective in inducing controlled atrophy of the gland and thereby terminating the inflammatory process. " 01/01/1983 - "Consequently, Ethibloc duct occlusion does not seem to be a superior alternative to other methods of producing exocrine atrophy in organs intended for transplantation." 11/01/1989 - "We conclude that Ethibloc occlusion is highly effective in inducing complete exocrine atrophy, thus abolishing the inflammatory process and preventing relapses of chronic pancreatitis and preserving the endocrine function from further impairment. " 04/01/1990 - "Partial pancreaticoduodenectomy with occlusion of the remaining tail of the pancreas with Ethibloc to induce rapid exocrine atrophy was introduced by us in January 1978 for the treatment of severe chronic pancreatitis affecting the head of the gland. " 11/01/1989 - "Partial duodenopancreatectomy and occlusion of the remaining ductal system by Ethibloc to induce rapid exocrine atrophy for treatment of severe chronic cephalic pancreatitis was introduced in our department in January of 1978. "
4.	Neoplasms (Cancer) 01/01/1989 - "Contrary to other angioocclusive treatment modalities, the concept of capillary occlusion with Ethibloc seems to achieve total tumor destruction." 10/01/1984 - "[Palliative embolization of kidney tumors using iodol-marked Ethibloc]." 09/01/1980 - "The second embolization with Ethibloc provoked a regression of the tumor." 01/01/1988 - "Two patients with abdominal hemorrhage from a hepatic tumor underwent transcatheter embolization using Ethibloc. " 01/01/1988 - "Control of hepatic tumor hemorrhage by transcatheter embolization with Ethibloc."
5.	Aneurysmal Bone Cysts 11/01/2009 - "The aim of this study is to assess the long-term results of Ethibloc injection in aneurysmal bone cysts (ABC). " 11/01/2009 - "Long-term follow-up of Ethibloc injection in aneurysmal bone cysts." 09/01/2005 - "Ethibloc injection may be performed as a primary treatment of aneurysmal bone cysts if the technique is followed with precision." 09/01/2005 - "The effects of percutaneous Ethibloc (Ethicon/Johnson & Johnson, St-Stevens-Woluwe, Belgium) injection into primary aneurysmal bone cysts were analysed. " 09/01/2005 - "Percutaneous Ethibloc injection in the treatment of primary aneurysmal bone cysts."

Related Drugs and Biologics

1.	Ethiodized Oil (Ethiodol)
2.	Amino Acids
3.	Anti-Bacterial Agents (Antibiotics)
4.	Ethanol (Ethyl Alcohol)
5.	Mitomycin (Mitomycin-C)
6.	Silicones
7.	Solutions
8.	Sclerosing Solutions (Sclerosing Agents)
9.	Phenylpropanolamine (Dexatrim)
10.	Glucose (Dextrose)

Related Therapies and Procedures

1.	Sclerotherapy
2.	Ligation
3.	Nephrectomy
4.	Pancreaticoduodenectomy
5.	Therapeutics